The data from this year's State of Secrets Sprawl report shows that AI is not creating a new secrets problem; it is accelerating every condition that already made secrets dangerous.
Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
A technical build log of the Multi-Agent Control Room, where AI agents pay invoices, escalate denials, and every action is ...
The post Chrome’s New Update Locks Down Your Login to End Session Theft Attacks appeared first on Android Headlines.
Connecting a local LLM to your browser can revolutionize automation.